Prof. Dr. Martin Biel
Department Pharmazie
- Zentrum für Pharmaforschung -
Ludwig-Maximilians-Universität München
Butenandtstr. 7, Haus C
81377 München
Germany
Since 1999 Professor for Pharmacology (C4), LMU München
Member of the German National Academy of Sciences Leopoldina and the Bavarian Academy of Sciences
Key publications
Fenske S, …, Biel M, Wahl-Schott C (2020) cAMP-dependent regulation of HCN4 controls the tonic entrainment process in sinoatrial node pacemaker cells. Nat Commun. 11:5555.
Böhm S,...,Biel M, Michalakis S, Becirovic E. (2020) A gene therapy for inherited blindness using dCas9-VPR-mediated transcripional activation. Science Advances 6:eaba5614.
Hammelmann V,…, Biel M (2019). Abolishing cAMP sensitivity in HCN2 pacemaker channels induces generalized seizures. JCI Insight pii: 126418.
Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA (2015) Two pore channels control Ebolavirus host cell entry and are drug targets for disease treatment. Science 347, 995-998.
Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M (1998) A family of hyperpolarization-activated mammalian cation channels. Nature 393:587-591.